Answers are grounded in this paper and cite their sources.
A series of thiadiazole‐based thioglycosides were synthesized as SGLT2 inhibitors from D‐glucose, D‐galactose and a variety of phenylacetic acids via a convenient protocol in 8 steps and evaluated in vivo with an oral glucose tolerance test (OGTT), and 5‐benzyl‐1,3,4‐thiadiazol‐2‐yl 1‐thio‐β‐D‐glucopyranoside (1a) was the most efficacious to suppress the blood glucose excursion during OGTT.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: